Research never stops

Target ID and validation

Evotec has established a world-leading platform to support the discovery and validation of innovative disease modifying targets across different therapeutic areas as well as aid target deconvolution following a phenotypic screen.

The Company’s offering includes: 

  • Differential expression studies followed by bioinformatics-driven data mining and hypothesis building
  • Gene knock-out and over-expression studies both in vitro and in vivo as well as access to relevant in vivo disease models
  • World-class ex vivo imaging technology platform using tissue sections to study cellular and molecular events
  • Phenotypic screening of complex cellular systems for hit identification
  • Target deconvolution using proteomics

For more detailed information, please click on this link or contact us at info@evotec.com.

Target ID and validation